Advertisement

Index by author

February 01, 1991; Volume 39,Issue 2

A

  1. Allegra, C J

    1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
      E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
      Molecular Pharmacology February 1991, 39 (2) 136-143;

  2. August, E M

    1. 3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
      E M August, E M Birks and W H Prusoff
      Molecular Pharmacology February 1991, 39 (2) 246-249;

B

  1. Ballesteros, L A

    1. Evidence of paired M2 muscarinic receptors.
      L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
      Molecular Pharmacology February 1991, 39 (2) 211-221;

  2. Beer, M

    1. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
      D M Grant, M Blum, M Beer and U A Meyer
      Molecular Pharmacology February 1991, 39 (2) 184-191;

  3. Bernstrom, K

    1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
      K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
      Molecular Pharmacology February 1991, 39 (2) 114-119;

  4. Bevan, R J

    1. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
      E M Cretton, M Y Xie, R J Bevan, N M Goudgaon, R F Schinazi and J P Sommadossi
      Molecular Pharmacology February 1991, 39 (2) 258-266;

  5. Bichajian, L H

    1. Evidence of paired M2 muscarinic receptors.
      L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
      Molecular Pharmacology February 1991, 39 (2) 211-221;

  6. Birks, E M

    1. 3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
      E M August, E M Birks and W H Prusoff
      Molecular Pharmacology February 1991, 39 (2) 246-249;

  7. Blum, M

    1. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
      D M Grant, M Blum, M Beer and U A Meyer
      Molecular Pharmacology February 1991, 39 (2) 184-191;

  8. Boksa, P

    1. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
      H Mount, R Quirion, I Chaudieu and P Boksa
      Molecular Pharmacology February 1991, 39 (2) 205-210;

  9. Brennscheidt, U

    1. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
      R Henschler, U Brennscheidt, R Mertelsmann and F Herrmann
      Molecular Pharmacology February 1991, 39 (2) 171-176;

  10. Brooks, B P

    1. [3H]opipramol labels a novel binding site and sigma receptors in rat brain membranes.
      C D Ferris, D J Hirsch, B P Brooks, A M Snowman and S H Snyder
      Molecular Pharmacology February 1991, 39 (2) 199-204;

  11. Burchell, B

    1. Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures.
      S Fournel-Gigleux, L Sutherland, N Sabolovic, B Burchell and G Siest
      Molecular Pharmacology February 1991, 39 (2) 177-183;

  12. Bylund, D B

    1. Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms.
      S B Jones, S P Halenda and D B Bylund
      Molecular Pharmacology February 1991, 39 (2) 239-245;

C

  1. Campbell, P T

    1. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
      P T Campbell, M Hnatowich, B F O'Dowd, M G Caron, R J Lefkowitz and W P Hausdorff
      Molecular Pharmacology February 1991, 39 (2) 192-198;

  2. Caron, M G

    1. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
      P T Campbell, M Hnatowich, B F O'Dowd, M G Caron, R J Lefkowitz and W P Hausdorff
      Molecular Pharmacology February 1991, 39 (2) 192-198;

  3. Catt, K J

    1. Novel angiotensin II antagonists distinguish amphibian from mammalian angiotensin II receptors expressed in Xenopus laevis oocytes.
      H Ji, K Sandberg and K J Catt
      Molecular Pharmacology February 1991, 39 (2) 120-123;

  4. Chaudieu, I

    1. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
      H Mount, R Quirion, I Chaudieu and P Boksa
      Molecular Pharmacology February 1991, 39 (2) 205-210;

  5. Chou, T C

    1. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
      X B Kong, W P Tong and T C Chou
      Molecular Pharmacology February 1991, 39 (2) 250-257;

  6. Chu, E

    1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
      E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
      Molecular Pharmacology February 1991, 39 (2) 136-143;

  7. Cieslinski, L B

    1. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
      M M McHale, L B Cieslinski, W K Eng, R K Johnson, T J Torphy and G P Livi
      Molecular Pharmacology February 1991, 39 (2) 109-113;

  8. Costa, E

    1. Stimulation of nerve growth factor biosynthesis in developing rat brain by reserpine: steroids as potential mediators.
      M Fabrazzo, E Costa and I Mocchetti
      Molecular Pharmacology February 1991, 39 (2) 144-149;

  9. Cretton, E M

    1. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
      E M Cretton, M Y Xie, R J Bevan, N M Goudgaon, R F Schinazi and J P Sommadossi
      Molecular Pharmacology February 1991, 39 (2) 258-266;

D

  1. De Costa, B R

    1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
      R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
      Molecular Pharmacology February 1991, 39 (2) 222-232;

  2. Diamond, J

    1. Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs.
      Y J Hei, K L MacDonell, J H McNeill and J Diamond
      Molecular Pharmacology February 1991, 39 (2) 233-238;

  3. Dinarello, C A

    1. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain.
      L G Miller, W R Galpern, K Dunlap, C A Dinarello and T J Turner
      Molecular Pharmacology February 1991, 39 (2) 105-108;

  4. Drake, J C

    1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
      E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
      Molecular Pharmacology February 1991, 39 (2) 136-143;

  5. Duniec, Z M

    1. Stimulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by phorbol ester: mediation by protein kinase C.
      Z M Duniec, P Nettesheim and T E Eling
      Molecular Pharmacology February 1991, 39 (2) 164-170;

  6. Dunlap, K

    1. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain.
      L G Miller, W R Galpern, K Dunlap, C A Dinarello and T J Turner
      Molecular Pharmacology February 1991, 39 (2) 105-108;

E

  1. Eling, T E

    1. Stimulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by phorbol ester: mediation by protein kinase C.
      Z M Duniec, P Nettesheim and T E Eling
      Molecular Pharmacology February 1991, 39 (2) 164-170;

  2. Eng, W K

    1. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
      M M McHale, L B Cieslinski, W K Eng, R K Johnson, T J Torphy and G P Livi
      Molecular Pharmacology February 1991, 39 (2) 109-113;

F

  1. Fabrazzo, M

    1. Stimulation of nerve growth factor biosynthesis in developing rat brain by reserpine: steroids as potential mediators.
      M Fabrazzo, E Costa and I Mocchetti
      Molecular Pharmacology February 1991, 39 (2) 144-149;

  2. Falck, J R

    1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
      K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
      Molecular Pharmacology February 1991, 39 (2) 114-119;

  3. Ferrendelli, C A

    1. Evidence of paired M2 muscarinic receptors.
      L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
      Molecular Pharmacology February 1991, 39 (2) 211-221;

  4. Ferris, C D

    1. [3H]opipramol labels a novel binding site and sigma receptors in rat brain membranes.
      C D Ferris, D J Hirsch, B P Brooks, A M Snowman and S H Snyder
      Molecular Pharmacology February 1991, 39 (2) 199-204;

  5. Fisher, A

    1. Evidence of paired M2 muscarinic receptors.
      L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
      Molecular Pharmacology February 1991, 39 (2) 211-221;

  6. Fitzpatrick, F A

    1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
      K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
      Molecular Pharmacology February 1991, 39 (2) 114-119;

  7. Fournel-Gigleux, S

    1. Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures.
      S Fournel-Gigleux, L Sutherland, N Sabolovic, B Burchell and G Siest
      Molecular Pharmacology February 1991, 39 (2) 177-183;

G

  1. Galpern, W R

    1. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain.
      L G Miller, W R Galpern, K Dunlap, C A Dinarello and T J Turner
      Molecular Pharmacology February 1991, 39 (2) 105-108;

  2. Ginns, E I

    1. Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
      P Montpied, A L Morrow, J W Karanian, E I Ginns, B M Martin and S M Paul
      Molecular Pharmacology February 1991, 39 (2) 157-163;

  3. Goudgaon, N M

    1. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
      E M Cretton, M Y Xie, R J Bevan, N M Goudgaon, R F Schinazi and J P Sommadossi
      Molecular Pharmacology February 1991, 39 (2) 258-266;

  4. Grant, D M

    1. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
      D M Grant, M Blum, M Beer and U A Meyer
      Molecular Pharmacology February 1991, 39 (2) 184-191;

  5. Gusovsky, F

    1. Selective effects of activation of protein kinase C isozymes on cyclic AMP accumulation.
      F Gusovsky and J S Gutkind
      Molecular Pharmacology February 1991, 39 (2) 124-129;

  6. Gutkind, J S

    1. Selective effects of activation of protein kinase C isozymes on cyclic AMP accumulation.
      F Gusovsky and J S Gutkind
      Molecular Pharmacology February 1991, 39 (2) 124-129;

H

  1. Halenda, S P

    1. Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms.
      S B Jones, S P Halenda and D B Bylund
      Molecular Pharmacology February 1991, 39 (2) 239-245;

  2. Hanchett, H E

    1. Evidence of paired M2 muscarinic receptors.
      L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
      Molecular Pharmacology February 1991, 39 (2) 211-221;

  3. Hausdorff, W P

    1. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
      P T Campbell, M Hnatowich, B F O'Dowd, M G Caron, R J Lefkowitz and W P Hausdorff
      Molecular Pharmacology February 1991, 39 (2) 192-198;

  4. Hei, Y J

    1. Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs.
      Y J Hei, K L MacDonell, J H McNeill and J Diamond
      Molecular Pharmacology February 1991, 39 (2) 233-238;

  5. Henschler, R

    1. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
      R Henschler, U Brennscheidt, R Mertelsmann and F Herrmann
      Molecular Pharmacology February 1991, 39 (2) 171-176;

  6. Herrmann, F

    1. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
      R Henschler, U Brennscheidt, R Mertelsmann and F Herrmann
      Molecular Pharmacology February 1991, 39 (2) 171-176;

  7. Hirsch, D J

    1. [3H]opipramol labels a novel binding site and sigma receptors in rat brain membranes.
      C D Ferris, D J Hirsch, B P Brooks, A M Snowman and S H Snyder
      Molecular Pharmacology February 1991, 39 (2) 199-204;

  8. Hnatowich, M

    1. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
      P T Campbell, M Hnatowich, B F O'Dowd, M G Caron, R J Lefkowitz and W P Hausdorff
      Molecular Pharmacology February 1991, 39 (2) 192-198;

J

  1. Jacobson, A E

    1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
      R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
      Molecular Pharmacology February 1991, 39 (2) 222-232;

  2. Jacobson, K A

    1. The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.
      C Nanoff, K A Jacobson and G L Stiles
      Molecular Pharmacology February 1991, 39 (2) 130-135;

  3. Jamis-Dow, C A

    1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
      E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
      Molecular Pharmacology February 1991, 39 (2) 136-143;

  4. Ji, H

    1. Novel angiotensin II antagonists distinguish amphibian from mammalian angiotensin II receptors expressed in Xenopus laevis oocytes.
      H Ji, K Sandberg and K J Catt
      Molecular Pharmacology February 1991, 39 (2) 120-123;

  5. Johnson, R K

    1. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
      M M McHale, L B Cieslinski, W K Eng, R K Johnson, T J Torphy and G P Livi
      Molecular Pharmacology February 1991, 39 (2) 109-113;

  6. Jones, S B

    1. Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms.
      S B Jones, S P Halenda and D B Bylund
      Molecular Pharmacology February 1991, 39 (2) 239-245;

K

  1. Karanian, J W

    1. Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
      P Montpied, A L Morrow, J W Karanian, E I Ginns, B M Martin and S M Paul
      Molecular Pharmacology February 1991, 39 (2) 157-163;

  2. Kim, C H

    1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
      R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
      Molecular Pharmacology February 1991, 39 (2) 222-232;

  3. Koeller, D M

    1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
      E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
      Molecular Pharmacology February 1991, 39 (2) 136-143;

  4. Kong, X B

    1. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
      X B Kong, W P Tong and T C Chou
      Molecular Pharmacology February 1991, 39 (2) 250-257;

L

  1. Lefkowitz, R J

    1. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
      P T Campbell, M Hnatowich, B F O'Dowd, M G Caron, R J Lefkowitz and W P Hausdorff
      Molecular Pharmacology February 1991, 39 (2) 192-198;

  2. Levy-Toledano, S

    1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
      K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
      Molecular Pharmacology February 1991, 39 (2) 114-119;

  3. Livi, G P

    1. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
      M M McHale, L B Cieslinski, W K Eng, R K Johnson, T J Torphy and G P Livi
      Molecular Pharmacology February 1991, 39 (2) 109-113;

M

  1. MacDonell, K L

    1. Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs.
      Y J Hei, K L MacDonell, J H McNeill and J Diamond
      Molecular Pharmacology February 1991, 39 (2) 233-238;

  2. Maclouf, J

    1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
      K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
      Molecular Pharmacology February 1991, 39 (2) 114-119;

  3. Mahboubi, A

    1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
      R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
      Molecular Pharmacology February 1991, 39 (2) 222-232;

  4. Malcolm, K

    1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
      K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
      Molecular Pharmacology February 1991, 39 (2) 114-119;

  5. Martin, B M

    1. Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
      P Montpied, A L Morrow, J W Karanian, E I Ginns, B M Martin and S M Paul
      Molecular Pharmacology February 1991, 39 (2) 157-163;

  6. McGee, J

    1. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
      K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
      Molecular Pharmacology February 1991, 39 (2) 114-119;

  7. McHale, M M

    1. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
      M M McHale, L B Cieslinski, W K Eng, R K Johnson, T J Torphy and G P Livi
      Molecular Pharmacology February 1991, 39 (2) 109-113;

  8. McNeill, J H

    1. Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs.
      Y J Hei, K L MacDonell, J H McNeill and J Diamond
      Molecular Pharmacology February 1991, 39 (2) 233-238;

  9. Mertelsmann, R

    1. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
      R Henschler, U Brennscheidt, R Mertelsmann and F Herrmann
      Molecular Pharmacology February 1991, 39 (2) 171-176;

  10. Meyer, U A

    1. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
      D M Grant, M Blum, M Beer and U A Meyer
      Molecular Pharmacology February 1991, 39 (2) 184-191;

  11. Miller, L G

    1. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain.
      L G Miller, W R Galpern, K Dunlap, C A Dinarello and T J Turner
      Molecular Pharmacology February 1991, 39 (2) 105-108;

  12. Miller, L J

    1. The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.
      X Molero and L J Miller
      Molecular Pharmacology February 1991, 39 (2) 150-156;

  13. Mocchetti, I

    1. Stimulation of nerve growth factor biosynthesis in developing rat brain by reserpine: steroids as potential mediators.
      M Fabrazzo, E Costa and I Mocchetti
      Molecular Pharmacology February 1991, 39 (2) 144-149;

  14. Molero, X

    1. The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.
      X Molero and L J Miller
      Molecular Pharmacology February 1991, 39 (2) 150-156;

  15. Montpied, P

    1. Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
      P Montpied, A L Morrow, J W Karanian, E I Ginns, B M Martin and S M Paul
      Molecular Pharmacology February 1991, 39 (2) 157-163;

  16. Morrow, A L

    1. Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
      P Montpied, A L Morrow, J W Karanian, E I Ginns, B M Martin and S M Paul
      Molecular Pharmacology February 1991, 39 (2) 157-163;

  17. Mount, H

    1. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
      H Mount, R Quirion, I Chaudieu and P Boksa
      Molecular Pharmacology February 1991, 39 (2) 205-210;

N

  1. Nanoff, C

    1. The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.
      C Nanoff, K A Jacobson and G L Stiles
      Molecular Pharmacology February 1991, 39 (2) 130-135;

  2. Nettesheim, P

    1. Stimulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by phorbol ester: mediation by protein kinase C.
      Z M Duniec, P Nettesheim and T E Eling
      Molecular Pharmacology February 1991, 39 (2) 164-170;

O

  1. O'Dowd, B F

    1. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
      P T Campbell, M Hnatowich, B F O'Dowd, M G Caron, R J Lefkowitz and W P Hausdorff
      Molecular Pharmacology February 1991, 39 (2) 192-198;

P

  1. Paul, S M

    1. Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
      P Montpied, A L Morrow, J W Karanian, E I Ginns, B M Martin and S M Paul
      Molecular Pharmacology February 1991, 39 (2) 157-163;

  2. Potter, L T

    1. Evidence of paired M2 muscarinic receptors.
      L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
      Molecular Pharmacology February 1991, 39 (2) 211-221;

  3. Prusoff, W H

    1. 3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
      E M August, E M Birks and W H Prusoff
      Molecular Pharmacology February 1991, 39 (2) 246-249;

Q

  1. Quirion, R

    1. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
      H Mount, R Quirion, I Chaudieu and P Boksa
      Molecular Pharmacology February 1991, 39 (2) 205-210;

R

  1. Reid, A

    1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
      R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
      Molecular Pharmacology February 1991, 39 (2) 222-232;

  2. Rice, K C

    1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
      R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
      Molecular Pharmacology February 1991, 39 (2) 222-232;

  3. Rothman, R B

    1. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
      R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
      Molecular Pharmacology February 1991, 39 (2) 222-232;

S

  1. Sabolovic, N

    1. Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures.
      S Fournel-Gigleux, L Sutherland, N Sabolovic, B Burchell and G Siest
      Molecular Pharmacology February 1991, 39 (2) 177-183;

  2. Sandberg, K

    1. Novel angiotensin II antagonists distinguish amphibian from mammalian angiotensin II receptors expressed in Xenopus laevis oocytes.
      H Ji, K Sandberg and K J Catt
      Molecular Pharmacology February 1991, 39 (2) 120-123;

  3. Schinazi, R F

    1. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
      E M Cretton, M Y Xie, R J Bevan, N M Goudgaon, R F Schinazi and J P Sommadossi
      Molecular Pharmacology February 1991, 39 (2) 258-266;

  4. Siest, G

    1. Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures.
      S Fournel-Gigleux, L Sutherland, N Sabolovic, B Burchell and G Siest
      Molecular Pharmacology February 1991, 39 (2) 177-183;

  5. Snowman, A M

    1. [3H]opipramol labels a novel binding site and sigma receptors in rat brain membranes.
      C D Ferris, D J Hirsch, B P Brooks, A M Snowman and S H Snyder
      Molecular Pharmacology February 1991, 39 (2) 199-204;

  6. Snyder, S H

    1. [3H]opipramol labels a novel binding site and sigma receptors in rat brain membranes.
      C D Ferris, D J Hirsch, B P Brooks, A M Snowman and S H Snyder
      Molecular Pharmacology February 1991, 39 (2) 199-204;

  7. Sommadossi, J P

    1. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
      E M Cretton, M Y Xie, R J Bevan, N M Goudgaon, R F Schinazi and J P Sommadossi
      Molecular Pharmacology February 1991, 39 (2) 258-266;

  8. Stiles, G L

    1. The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.
      C Nanoff, K A Jacobson and G L Stiles
      Molecular Pharmacology February 1991, 39 (2) 130-135;

  9. Sutherland, L

    1. Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures.
      S Fournel-Gigleux, L Sutherland, N Sabolovic, B Burchell and G Siest
      Molecular Pharmacology February 1991, 39 (2) 177-183;

T

  1. Tong, W P

    1. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
      X B Kong, W P Tong and T C Chou
      Molecular Pharmacology February 1991, 39 (2) 250-257;

  2. Torphy, T J

    1. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
      M M McHale, L B Cieslinski, W K Eng, R K Johnson, T J Torphy and G P Livi
      Molecular Pharmacology February 1991, 39 (2) 109-113;

  3. Turner, T J

    1. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain.
      L G Miller, W R Galpern, K Dunlap, C A Dinarello and T J Turner
      Molecular Pharmacology February 1991, 39 (2) 105-108;

X

  1. Xie, M Y

    1. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
      E M Cretton, M Y Xie, R J Bevan, N M Goudgaon, R F Schinazi and J P Sommadossi
      Molecular Pharmacology February 1991, 39 (2) 258-266;

Y

  1. Yeh, G C

    1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
      E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
      Molecular Pharmacology February 1991, 39 (2) 136-143;

Z

  1. Zhang, R

    1. Evidence of paired M2 muscarinic receptors.
      L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
      Molecular Pharmacology February 1991, 39 (2) 211-221;

  2. Zinn, S

    1. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
      E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
      Molecular Pharmacology February 1991, 39 (2) 136-143;
Back to top

In this issue